» Articles » PMID: 3257774

Effective Immunization Against Cutaneous Leishmaniasis with Defined Membrane Antigens Reconstituted into Liposomes

Overview
Journal J Immunol
Date 1988 Feb 15
PMID 3257774
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The abundant Leishmania promastigote surface Ag gp63 and Leishmania promastigote lipophosphoglycan were reconstituted into liposomes and used as a vaccine against the agent of New World cutaneous leishmaniasis, Leishmania mexicana. The Ag were inoculated s.c., i.p., and i.v. into CBA/ca and BALB/c mice. Even at low Ag dosages, 8 to 10 micrograms/mouse, the Ag induced appreciable levels of protection. In CBA/ca mice complete protection was obtained by s.c. inoculation of antigen-containing liposomes. Protection could be transferred with T cells to naive mice. Interestingly, the Ag-containing liposomes did not cause the disease exacerbation observed in previous vaccine studies with crude parasite extracts.

Citing Articles

A Ferrier glycosylation/-dihydroxylation strategy to synthesize spp. lipophosphoglycan-associated βGal(1,4)Man disaccharide.

Budhathoki D, Deore B, Finn M, Sanhueza C RSC Adv. 2022; 12(43):28207-28216.

PMID: 36320230 PMC: 9530798. DOI: 10.1039/d2ra05158c.


Vaccination in Leishmaniasis: A Review Article.

Abdellahi L, Iraji F, Mahmoudabadi A, Hejazi S Iran Biomed J. 2021; 26(1):1-35.

PMID: 34952558 PMC: 8784899. DOI: 10.52547/ibj.26.1.35.


The Role of Sialic Acids in the Establishment of Infections by Pathogens, With Special Focus on .

Cavalcante T, Medeiros M, Mule S, Palmisano G, Stolf B Front Cell Infect Microbiol. 2021; 11:671913.

PMID: 34055669 PMC: 8155805. DOI: 10.3389/fcimb.2021.671913.


Unidirectional Presentation of Membrane Proteins in Nanoparticle-Supported Liposomes.

Chen W, Cai Y, Fu Q, Chen B, Guo J, Chou J Angew Chem Int Ed Engl. 2019; 58(29):9866-9870.

PMID: 30990942 PMC: 6660371. DOI: 10.1002/anie.201903093.


Liposomal adjuvant development for leishmaniasis vaccines.

Askarizadeh A, Jaafari M, Khamesipour A, Badiee A Ther Adv Vaccines. 2017; 5(4-5):85-101.

PMID: 29201374 PMC: 5697592. DOI: 10.1177/2051013617741578.